Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry

B. Glintborg, I. Juul Sørensen, Dote Vendelbo Jensen, N. S. Krogh, Anne Gitte Loft, Ada Colic, Jakob Espesen, J. Olsen, O. Hendricks, J Grydehøj, Inger Marie Jensen Hansen, M. V. Sørensen, Stavros Chrysidis, N Manilo, M. Klarlund, L.S. Andersen, H Nordin, S. Kristensen, M.L. Hetland

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceFormidling

OriginalsprogEngelsk
Publikationsdato2016
StatusUdgivet - 2016
BegivenhedEULAR 2016 - ExCel London, London, Storbritannien
Varighed: 8. jun. 201611. jun. 2016

Konference

KonferenceEULAR 2016
LokationExCel London
LandStorbritannien
ByLondon
Periode08/06/201611/06/2016

Citer dette

Glintborg, B., Juul Sørensen, I., Vendelbo Jensen, D., Krogh, N. S., Loft, A. G., Colic, A., ... Hetland, M. L. (2016). Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry. Abstract fra EULAR 2016, London, Storbritannien.
Glintborg, B. ; Juul Sørensen, I. ; Vendelbo Jensen, Dote ; Krogh, N. S. ; Loft, Anne Gitte ; Colic, Ada ; Espesen, Jakob ; Olsen, J. ; Hendricks, O. ; Grydehøj, J ; Jensen Hansen, Inger Marie ; Sørensen, M. V. ; Chrysidis, Stavros ; Manilo, N ; Klarlund, M. ; Andersen, L.S. ; Nordin, H ; Kristensen, S. ; Hetland, M.L. / Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry. Abstract fra EULAR 2016, London, Storbritannien.
@conference{5737392783cb416ba76207c02b90ef9e,
title = "Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry",
author = "B. Glintborg and {Juul S{\o}rensen}, I. and {Vendelbo Jensen}, Dote and Krogh, {N. S.} and Loft, {Anne Gitte} and Ada Colic and Jakob Espesen and J. Olsen and O. Hendricks and J Grydeh{\o}j and {Jensen Hansen}, {Inger Marie} and S{\o}rensen, {M. V.} and Stavros Chrysidis and N Manilo and M. Klarlund and L.S. Andersen and H Nordin and S. Kristensen and M.L. Hetland",
year = "2016",
language = "English",
note = "null ; Conference date: 08-06-2016 Through 11-06-2016",

}

Glintborg, B, Juul Sørensen, I, Vendelbo Jensen, D, Krogh, NS, Loft, AG, Colic, A, Espesen, J, Olsen, J, Hendricks, O, Grydehøj, J, Jensen Hansen, IM, Sørensen, MV, Chrysidis, S, Manilo, N, Klarlund, M, Andersen, LS, Nordin, H, Kristensen, S & Hetland, ML 2016, 'Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry' EULAR 2016, London, Storbritannien, 08/06/2016 - 11/06/2016, .

Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry. / Glintborg, B.; Juul Sørensen, I.; Vendelbo Jensen, Dote; Krogh, N. S.; Loft, Anne Gitte; Colic, Ada; Espesen, Jakob; Olsen, J.; Hendricks, O.; Grydehøj, J; Jensen Hansen, Inger Marie; Sørensen, M. V.; Chrysidis, Stavros; Manilo, N; Klarlund, M.; Andersen, L.S.; Nordin, H; Kristensen, S.; Hetland, M.L.

2016. Abstract fra EULAR 2016, London, Storbritannien.

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceFormidling

TY - ABST

T1 - Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry

AU - Glintborg, B.

AU - Juul Sørensen, I.

AU - Vendelbo Jensen, Dote

AU - Krogh, N. S.

AU - Loft, Anne Gitte

AU - Colic, Ada

AU - Espesen, Jakob

AU - Olsen, J.

AU - Hendricks, O.

AU - Grydehøj, J

AU - Jensen Hansen, Inger Marie

AU - Sørensen, M. V.

AU - Chrysidis, Stavros

AU - Manilo, N

AU - Klarlund, M.

AU - Andersen, L.S.

AU - Nordin, H

AU - Kristensen, S.

AU - Hetland, M.L.

PY - 2016

Y1 - 2016

M3 - Conference abstract for conference

ER -

Glintborg B, Juul Sørensen I, Vendelbo Jensen D, Krogh NS, Loft AG, Colic A et al. Three months* clinical outcomes from a Nationwide Non-Medical Switch from originator to biosimilar infliximab in patients with inflammatory artrhritis. Results from the Danbio registry. 2016. Abstract fra EULAR 2016, London, Storbritannien.